Literature DB >> 18703528

IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.

R Engelmann1, J Brandt, M Eggert, K Karberg, A Krause, G Neeck, B Mueller-Hilke.   

Abstract

OBJECTIVE: Antibody subclasses reflect specific immunological processes and may be indicative of the underlying pathological pattern in an autoimmune disease like RA. We therefore quantified anti-cyclic citrullinated peptides (CCP) and anti- citrullinated vimentin (MCV) IgG subclass titres in RA patients and compared them with the respective titres of antibodies directed against the varicella zoster virus (VZV) and to total serum titres.
METHODS: Sera of 77 patients fulfilling the ACR criteria for RA were collected. An IgG subclass-specific ELISA system was then established and combined with commercially available MCV, CCP and VZV pre-coated microtitre plates.
RESULTS: Even though IgG1 is the predominant subclass among antibodies against CCP and MCV in RA patients, IgG4 is second with respect to titres and frequencies. This increase in IgG4 among RA-specific antibodies is independent of disease duration and does not reflect a general skewing of the immune response in these patients as overall serum titres and antibodies directed against VZV show a normal distribution of IgG1, IgG2, IgG3 and IgG4.
CONCLUSION: Elevated IgG4 titres are specific for auto-antibodies against citrullinated antigens in RA and are indicative of a Th2-biased environment during the generation of auto-reactive plasma cells. We discuss here an indirect role for IgG4 auto-antibodies in hindering the elimination of auto-reactive B and plasma cells and thus driving the autoimmune process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703528     DOI: 10.1093/rheumatology/ken336

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  23 in total

1.  Improving seroreactivity-based detection of glioma.

Authors:  Nicole Ludwig; Andreas Keller; Sabrina Heisel; Petra Leidinger; Veronika Klein; Stefanie Rheinheimer; Claudia U Andres; Bernhard Stephan; Wolf-Ingo Steudel; Norbert M Graf; Bernhard Burgeth; Joachim Weickert; Hans-Peter Lenhof; Eckart Meese
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

2.  Decreased IgG4 ACPA levels in responders and increased CD1c+ classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy.

Authors:  Robby Engelmann; Sven Nekarda; Daniela Kuthning; Christian Kneitz; Brigitte Müller-Hilke
Journal:  Clin Rheumatol       Date:  2018-03-03       Impact factor: 2.980

3.  Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis.

Authors:  Wei Wang; Jinming Li
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 2.980

4.  Comparison of serological markers between ACPA⁺ and ACPA⁻ of RA patients.

Authors:  Chunhua Xun; Yong Zhao
Journal:  Rheumatol Int       Date:  2011-01-19       Impact factor: 2.631

5.  Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis.

Authors:  Guigao Lin; Jinming Li
Journal:  Rheumatol Int       Date:  2010-01-06       Impact factor: 2.631

Review 6.  [Antibodies against citrullinated peptides in clinical practice and research].

Authors:  R Engelmann; B Müller-Hilke
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

Review 7.  Follicular helper T cells in rheumatoid arthritis.

Authors:  Meixing Yu; Vanesssa Cavero; Qiao Lu; Hong Li
Journal:  Clin Rheumatol       Date:  2015-07-31       Impact factor: 2.980

8.  Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor.

Authors:  Abbas Agaimy; Bruno Märkl
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

9.  A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.

Authors:  Caroline Grönwall; Lisa Liljefors; Holger Bang; Aase H Hensvold; Monika Hansson; Linda Mathsson-Alm; Lena Israelsson; Vijay Joshua; Anna Svärd; Ragnhild Stålesen; Philip J Titcombe; Johanna Steen; Luca Piccoli; Natalia Sherina; Cyril Clavel; Elisabet Svenungsson; Iva Gunnarsson; Saedis Saevarsdottir; Alf Kastbom; Guy Serre; Lars Alfredsson; Vivianne Malmström; Johan Rönnelid; Anca I Catrina; Karin Lundberg; Lars Klareskog
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

10.  Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.

Authors:  Gustavo Carbone; Augusta Wilson; Sean A Diehl; Janice Bunn; Sheldon M Cooper; Mercedes Rincon
Journal:  Int J Biol Sci       Date:  2013-03-07       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.